Loading…
Efficacy of remote audio‐visual system versus standard onsite buddy system to monitor the doffing of personal protective equipment during COVID‐19 pandemic: An observational study
Objectives Literature states a higher self‐contamination rate among healthcare workers (HCWs) while doffing personal protective equipment (PPE). During the Covid‐19 pandemic, onsite trained observers were not always available to monitor PPE compliance. The remote audio‐visual doffing surveillance (R...
Saved in:
Published in: | The International journal of health planning and management 2024-03, Vol.39 (2), p.530-540 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
Literature states a higher self‐contamination rate among healthcare workers (HCWs) while doffing personal protective equipment (PPE). During the Covid‐19 pandemic, onsite trained observers were not always available to monitor PPE compliance. The remote audio‐visual doffing surveillance (RADS) system has the potential to overcome this limitation. We aimed to compare the efficacy of this real‐time RADS system against the onsite buddy system for monitoring the doffing of PPE.
Methods
This prospective, observational study was carried out at our tertiary care centre in northern India. 200 HCWs who cared for Covid‐19 patients in the intensive care units/operation theatres were included. Group A included HCWs who performed doffing with the help of an onsite trained observer and group B included HCWs who performed doffing with the RADS system. An independent observer noted the error at any step using the CDC doffing checklist, in both groups. An online questionnaire to analyse the level of satisfaction post‐doffing was also surveyed.
Results
The proportion of errors committed during doffing was significantly lower in group B compared to group A with a low relative risk of 0.34 (95% CI 0.22–0.51) (p |
---|---|
ISSN: | 0749-6753 1099-1751 |
DOI: | 10.1002/hpm.3754 |